| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:3216.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
From the Department of Pharmacology, College of Physicians and Surgeons of Columbia University, New York, NY.
Correspondence to Robert S. Kass, PhD, Department of Pharmacology, College of Physicians and Surgeons of Columbia University, 630 W 168th St, PH 7W 318, New York, NY 10032. E-mail rsk20{at}columbia.edu
Background Mutations in SCN5A, the gene coding for the human cardiac Na+ channel
-subunit, are associated with variant 3 of the long-QT syndrome (LQT-3). Several LQT-3 mutations promote a mode of Na+ channel gating in which a fraction of channels fail to inactivate, contributing sustained Na+ channel current (Isus), which can delay repolarization and prolong the QT interval. Here, we investigate the possibility that stimulation of protein kinase C (PKC) may modulate Isus, which is prominent in disease-related Na+ channel mutations.
Methods and Results We measured the effects of PKC stimulation on Na+ currents in human embryonic kidney (HEK 293) cells expressing 3 previously reported disease-associated Na+ channel mutations (Y1795C, Y1795H, and
KPQ). We find that the PKC activator 1-oleoyl-2-acetyl-sn-glycerol (OAG) significantly reduced Isus in the mutant but not wild-type channels. The effect of OAG on Isus was reduced by the PKC inhibitor staurosporine (2.5 µmol/L), ablated by the mutation S1503A, and mimicked by the mutation S1503D. Isus recorded in myocytes isolated from mice expressing
KPQ channels was similarly inhibited by OAG exposure or stimulation of
1-adrenergic receptors by phenylephrine. The actions of phenylephrine on Isus were blocked by the PKC inhibitor chelerythrine.
Conclusions We conclude that stimulation of PKC inhibits channel bursting in disease-linked mutations via phosphorylation-induced alteration of the charge at residue 1503 of the Na+ channel
-subunit. Sympathetic nerve activity may contribute directly to suppression of mutant channel bursting via
-adrenergic receptormediated stimulation of PKC.
Key Words: sodium channels long-QT syndrome kinases arrhythmia
This article has been cited by other articles:
![]() |
S Talon, M.-A Giroux-Metges, J.-P Pennec, C Guillet, H Gascan, and M Gioux Rapid protein kinase C-dependent reduction of rat skeletal muscle voltage-gated sodium channels by ciliary neurotrophic factor J. Physiol., June 15, 2005; 565(3): 827 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oginosawa, T. Nagatomo, H. Abe, N. Makita, J. C. Makielski, and Y. Nakashima Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome Cardiovasc Res, January 1, 2005; 65(1): 138 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kurokawa, H. K. Motoike, J. Rao, and R. S. Kass Regulatory actions of the A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA phosphorylation PNAS, November 16, 2004; 101(46): 16374 - 16378. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |